Previous Article | Next Article ![]()
Infection and Immunity, December 2003, p. 6835-6843, Vol. 71, No. 12
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.12.6835-6843.2003
Copyright © 2003, American
Society for
Microbiology. All Rights Reserved.
Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107,1 The Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York 10021,2 Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 191043
Received 25 June 2003/ Returned for modification 17 August 2003/ Accepted 18 September 2003
|
|
|---|
KO mice did not result in larval killing. These findings
suggest that IgG from mice immunized with live L3 requires complement
activation and neutrophils for killing of L3 through an
antibody-dependent cellular cytotoxicity (ADCC) mechanism.
This is in contrast to the results of investigations using IgM from
mice immunized with live L3 and IgG from mice immunized with larval
antigens soluble in deoxycholate in which protective immunity was shown
to be ADCC independent. Western blot analyses with immune IgM and IgG
identified few antigens recognized by all protective antibody isotypes.
Results from immunoelectron microscopy demonstrated that the protective
antibodies bound to different regions in the L3. It was therefore
concluded that while IgM and IgG antibodies are both protective against
larval S. stercoralis, they recognize different antigens and
utilize different killing
mechanisms. |
|
|---|
To gain an understanding of how the immune response eliminates the larval stages of S. stercoralis, a mouse model was developed. In this model it was demonstrated that immunization of mice with live infective third-stage larvae (L3) induced protective immunity which resulted in the elimination of approximately 90% of the challenge larvae within 24 h (1). Serum collected from mice 1 week after a booster immunization could passively transfer immunity into naïve mice (4). Parasite-specific IgG1, IgM, and IgA titers were elevated in the immunized mice (1); however, it was shown that IgM was the only antibody isotype capable of participating in parasite elimination at that time. IgM-mediated killing of the L3 was dependent on cell contact, the presence of granulocytes, and complement activation (4). Furthermore, it was shown that IgM from immunized mice could passively transfer immunity to naïve IL-5 knockout (KO) mice, which are deficient in eosinophils (20), thus suggesting that neutrophils were the required granulocyte for the IgM-dependent killing mechanism (15).
IgG and not IgM was protective against larval S. stercoralis in mice immunized with L3 antigens solubilized in deoxycholate (DOC) (16). This observation suggested that IgG could function in the killing of S. stercoralis L3 and that the development of a protective IgG response was dependent on how the mice were immunized. IgG has been shown to be responsible for immunity-dependent protection in other nematode infections, including Strongyloides ratti (25), Nematospiroides dubius (41), Trichinella spiralis (3), and Brugia pahangi (24). The goal of the present study was therefore to determine whether and when IgG from mice immunized with live L3 functioned as a component of the larval killing process. In addition, comparisons were made between the mechanisms used by IgM and IgG to kill the larvae. Finally, the molecular and morphological targets used by IgM and IgG were identified.
|
|
|---|
KO mice (both on a C57BL/6 background)
were produced in our breeding colony in the Laboratory Animal Sciences
facility at Thomas Jefferson University (Philadelphia, Penn.). IL-5 KO
mice were a generous gift from Manfred Kopf of the Basel Institute for
Immunology (20), and
FcR
KO mice were a generous gift from Jeffery Ravetch of
Rockefeller University
(37). All mice were
housed in microisolator boxes (Lab Products Inc., Maywood, N.J.) and
kept in a climate-controlled environment. S. stercoralis L3 were harvested from the feces of an infected laboratory dog as previously described (33). L3 were washed five times with a 1:1 mixture of NCTC-135 and IMDM supplemented with 100 U of penicillin (Gibco, Grand Island, N.Y.)/ml, 0.1 mg of streptomycin (Gibco)/ml, and 0.1 mg of gentamicin (Gibco)/ml.
Live immunization and challenge. Mice were immunized with 5,000 live L3 on day 0 and received a similar booster immunization on day 14. Immunized mice received challenge infections of 50 S. stercoralis L3 (contained in diffusion chambers) at various time points after the booster immunization. Diffusion chambers were made from 14-mm-diameter Lucite rings covered with 2.0-µm-pore-size polycarbonate Isopore membranes (Millipore, Bedford, Ma.). The rings are glued together with a 1:1 mixture of 1,2-dichloroethane (Sigma, St. Louis, Mo.) and acryloid resin (Rohm and Haas Co., Philadelphia, Pa.). The membranes are attached to the rings with cyanoacrylate (Super Glue, Hollis, N.Y.). The completed diffusion chambers were then sterilized by exposure to 100% ethylene oxide gas followed by 12 h of aeration. Diffusion chambers containing the challenge L3 were placed in a subcutaneous pocket on the rear flank of the mice. At 24 h later, the diffusion chambers were recovered and larval survival was determined on the basis of morphology and mobility of the worms. Host cells found in the diffusion chambers were centrifuged onto slides through the use of a Cytospin 3 apparatus (Shandon, Pittsburgh, Pa.) and then stained for differential counts with DiffQuik (Baxter Healthcare, Miami, Fla.).
Preparation and immunization with soluble antigen. Mice were immunized with larval antigens solubilized in DOC as previously described (17). Briefly, S. stercoralis L3 were incubated in a petri dish for 20 min with a 1% solution of low-melt agarose (Type I-A Low EEO; Sigma). Phosphate-buffered saline (PBS) supplemented with antibiotics (100 U of penicillin/ml, 0.1 mg of streptomycin/ml, and 0.1 mg of gentamicin/ml) was added, and larvae that migrated into the PBS were harvested and stored at -80°C in 50% glycerol-PBS. L3 were homogenized on ice in PBS supplemented with a protease inhibitor cocktail (Sigma) and 50 mM EDTA and then sonicated. DOC-soluble L3 antigens were obtained first by extraction from the L3 with PBS and then by extraction of the remaining pellet with 20 mM Tris-HCl-0.5% DOC in the presence of protease inhibitors; the extracted antigens were then dialyzed overnight in PBS. DOC antigens (DOC Ag) were then passed through a 0.2-µm-pore-size syringe filter, and protein concentrations were determined with a Micro BCA protein assay (Pierce, Rockford, Ill.).
Mice were immunized with soluble antigens through the use of the following protocol: 2% aluminum hydroxide low-viscosity Rehydragel (alum) (Reheis, Inc., Berkeley Heights, N.J.) was diluted 1:10 with PBS containing 25 µg of DOC Ag. Mice were injected with 200 µl of the solution in the nape of the neck on days 0 and 14 which was followed on day 28 by a challenge infection consisting of L3 contained within a diffusion chamber (which was recovered 4 days later).
Serum transfers and antibody purification. Serum used in transfers was obtained from mice which were immunized and challenged as described above. The serum was collected at either 3 or 5 weeks after a booster immunization from mice immunized with live L3 and 18 days after a booster immunization from mice immunized with the DOC Ag. Serum (recovered from blood after exsanguination of mice anesthetized with isoflurane) was filter sterilized with a 0.2-µm-pore-size syringe filter and stored at -80°C.
Serum was passed over a protein G-Sepharose column (Pharmacia, Peapack, N.J.) to purify the IgG fraction. The flowthrough volume containing IgA, IgE, and IgM was then passed over IgA and IgE affinity columns, leaving only IgM in the flowthrough solution. Antibody fractions were eluted from the column with 0.5 M acetic acid (pH 3.0), neutralized with saturated Tris-HCl (pH 9.8), dialyzed overnight in PBS, and concentrated with an Ultrafree-15 centrifugal filter device (Millipore). Total IgM and IgG concentrations in the serum were determined by enzyme-linked immunosorbent assay (as described below) before and after purification.
Passive transfer of the purified antibody and whole immune sera was done by injection either directly into the diffusion chamber or into the subcutaneous pocket around the implanted diffusion chamber at the time of challenge. No differences were seen between the results obtained with each method. The amount of purified antibody transferred into the mice was equal to the amount of antibody found in 100 µl of either unfractionated naive or immune serum. The antibody was administered in 200 µl of PBS. All serum transfer experiments were terminated at 24 h postchallenge.
Cell and complement depletion. Depletion of granulocytes was accomplished using the monoclonal antibody (MAb) RB6-8C5 (18). Mice were given an intraperitoneal injection of 0.5 mg of antibody 3 days before the challenge as well as at the time of challenge. An isotype control antibody was not included in these studies, because multiple previous experiments have shown that these antibodies have no effect on parasite viability (31), (32). Granulocyte depletion was verified with blood smears taken at the time of recovery and from analysis of the fluid in the diffusion chambers.
Cobra venom factor (CVF) (Sigma) (used for depletion of complement) was injected (400 µg per kg of body weight) intraperitoneally into mice at 24 h prior to and at the time of challenge (14).
Enzyme-linked immunosorbent assay. Maxisorp 96-well plates (Nunc Inc., Naperville, Il.) were coated with 2 µg of rat anti-mouse IgG (Sigma)/ml or 5 µg of rat anti-mouse IgM (Pharmingen, San Diego, Calif.)/ml overnight at 4°C. Plates were then blocked with borate buffer solution (0.17 M boric acid, 0.12 M NaCl, 0.05% Tween 20, 0.025% bovine serum albumin, 1 mM EDTA, pH 8.2) at room temperature (RT) for 30 min. The plates were washed with distilled water, and the samples and appropriate standards were serially diluted in borate buffer solution and then incubated for 2 h at 37°C. The plates were washed with distilled water and then incubated with biotinylated goat anti-mouse IgG or IgM (Pharmingen) for 1 h at RT. The plates were washed, and ExtrAvidin peroxidase (Sigma) was added for 30 min at RT. After the final washing, the peroxidase substrate ABTS [2,2'-azino-di-(3-ethylbenzthiazoline-6-sulfonate)] (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) was added. ABTS color reactions were measured at 410 nm on an MR5000 microplate reader (Dynatech Laboratories, Chantilly, Va.).
Western blotting. DOC-soluble L3 antigens (100 µg) were separated in a sodium dodecyl sulfate-8 to 16% polyacrylamide electrophoresis slab gel on a Mini-PROTEAN 3 apparatus (Bio-Rad Corporation, Hercules, Calif.). Electrophoresis was run at 30 mA for 2 h, after which proteins were transferred to a nitrocellulose membrane (Bio-Rad) through the use of a Trans-Blot apparatus (Bio-Rad) at 100 V for 1 h at 4°C. The nitrocellulose membranes were then blocked with 5% Carnation brand nonfat dry instant milk (Nestlé Food, Glendale, Calif.). The membranes were washed in PBS-0.05% Tween 20, cut into strips, and then incubated in a 1:1000 dilution of whole serum for 1 h at RT. The membrane strips were washed in PBS-0.05% Tween 20 and then treated with anti-mouse IgG horseradish peroxidase-conjugated antibody (Pharmingen) or anti-mouse IgM F(ab')2 horseradish peroxidase-conjugated antibody (ICN/Cappell, Aurora, Ohio) for 45 min at RT and washed. Western blots were processed using enhanced chemiluminescence (NEN Life Sciences Products Inc., Boston, Mass.) and then developed with Biomax ML film (Eastman Kodak, Rochester, N.Y.).
Electron microscopy. L3 were fixed for 30 min in 0.25% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) containing 1% sucrose, embedded, and then processed for immunoelectron microscopy. Thin sections of embedded worms were incubated with purified IgM (diluted 1:5) or IgG (diluted 1:100) from control and immunized mice followed by incubation with a suspension of 15-nm-diameter gold particles coated with protein A, as previously described (19, 21, 22).
Statistics. All experiments consisted of at least five mice per group; experiments were performed at least twice, and consistent results were obtained from the repeated experiments. Data presented are from all of the performed experiments. Statistical analysis was determined by multifactorial analysis of variance; probability values of less than 0.05 were considered significant.
|
|
|---|
![]() View larger version (19K): [in a new window] |
FIG. 1. Mean
percentage of live larval recovery from mice that received the transfer
of whole immune sera, purified IgM, and purified IgG recovered 3 weeks
(A) and 5 weeks (B) after booster immunization with
live L3. The data represent the means and standard deviations of the
results for 10 animals per group. The asterisks indicate statistical
differences (P 0.05) from control
values.
|
![]() View larger version (23K): [in a new window] |
FIG. 2. Effect
of CVF treatment of mice that have received transfer of naïve
and immune IgG on the survival of challenge larvae. The data represent
the means and standard deviations of the results for 10 animals per
group. The asterisks indicate statistical differences (P
0.05) from control
values.
|
![]() View larger version (22K): [in a new window] |
FIG. 3. Effect
of granulocyte depletion with MAb RB6-8C5 on immunity transferred with
purified immune IgG. The data represent the means and standard
deviations of the results for 10 animals per group. The asterisks
indicate statistical differences (P 0.05) from
control
values.
|
![]() View larger version (17K): [in a new window] |
FIG. 4. Transfer
of naïve and immune IgG into wild-type C57BL/6J mice and IL-5
KO mice to determine whether eosinophils are required for protective
immunity. The data represent the means and standard deviations of the
results for 10 animals per group. The asterisks indicate statistical
differences (P 0.05) from control
values.
|
KO mice are missing the
-chain
required for Fc
RI, Fc
RIII, and Fc
R receptor
surface expression (37).
Cells in these mice are therefore unable to bind to IgG and IgE.
FcR
KO mice were immunized with L3 to determine whether
protective immunity would be different from that seen with wild-type
mice. Immunization of FcR
KO mice with challenge either 1 week
after the booster immunization (when IgM was the functioning isotype)
(4) or 3 weeks after the
booster immunization (when IgM and IgG were the functioning isotypes)
resulted in protective immunity (Fig.
5). However, transfer of purified IgG (recovered 3 weeks after booster
immunization with live L3) into FcR
KO mice failed to transfer
immunity (Fig.
6A). This was in marked contrast to the results seen with IgG recovered from
mice immunized with DOC Ag, which could transfer immunity to the
FcR
KO mice (Fig.
6B). Diffusion chambers
implanted in wild-type and FcR
KO mice that received either no
IgG, control IgG, or IgG from animals immunized with live or
solubilized L3 all contained equal numbers of infiltrating neutrophils.
The numbers of infiltrating neutrophils ranged from 4 x
106 to 8 x 106, with no statistical
differences between groups.
![]() View larger version (23K): [in a new window] |
FIG. 5. Effect
of immunization of C57BL/6J and FcR KO mice on the survival of
challenge larvae at 1 week (A) and 3 weeks (B)
after booster immunization. The data represent the means and standard
deviations of the results for 12 animals per group for the experiment
at 1 week after booster immunization and 5 animals per group for the
experiment at 3 weeks after booster immunization. The asterisks
indicate statistical differences (P 0.05) from
control
values.
|
![]() View larger version (25K): [in a new window] |
FIG. 6. Effect
on larval survival of transfer of immune IgG from mice immunized with
live L3 (A) or with soluble DOC antigen (B) into
C57BL/6J and FcR KO mice. The data represent the means and
standard deviations of results for 10 animals per group. The asterisks
indicate statistical differences (P 0.05) from
control
values.
|
![]() View larger version (54K): [in a new window] |
FIG. 7. Antigen
recognition in Western blot analysis of protective IgM and
IgG (recovered from mice 3 weeks after immunization with live L3) from
solubilized S. stercoralis larval antigens. The bars represent
bands recognized by both IgM and
IgG.
|
![]() View larger version (146K): [in a new window] |
FIG. 8. Immunoelectron
microscopy performed to determine where protective IgM recovered 1 week
after booster immunization bound to the larvae of S.
stercoralis. Cu, cuticle; g, glandular esophagus granules. The
thin arrows indicate labeling in the basal cuticle-hypodermis area, the
thick arrows indicate labeling on the surface of the cuticle, and the
arrowheads indicate labeling in the coelomic cavity. Bar, 250
nm.
|
![]() View larger version (127K): [in a new window] |
FIG. 9. Immunoelectron
microscopy performed to determine where protective IgG, recovered at 3
weeks after booster immunization, bound to the larvae of S.
stercoralis. Cu, cuticle; g, glandular esophagus granules. The
thin arrows indicate labeling in the basal cuticle-hypodermis area; the
arrowheads indicate labeling in the coelomic cavity. Bar, 250
nm.
|
|
|
|---|
Mice were treated with CVF to eliminate complement activation and thereby determine whether activation of the complement cascade is required for IgG to function in killing the larvae. It was determined that IgG could not transfer immunity when the recipient mice were treated to block complement activation. Both the alternative and the classical pathways of complement activation have been shown to occur on the surface S. stercoralis L3 in vitro (7), and it was previously shown that complement activation was also required for IgM to effect larval killing in mice (4). In vitro studies have also shown a requirement for complement activation in killing the helminths T. spiralis (38), Loa loa (30), Angiostrongylus cantonensis (34), Nippostrongylus brasiliensis (8), and Schistosoma mansoni (2) and in the control of S. mansoni in vivo (10, 39).
In previous studies it was shown that contact between host cells and the parasites was required for IgM to kill the larvae of S. stercoralis. Furthermore, depletion of granulocytes with the MAb RB6-8C5 also eliminated IgM-dependent immunity (4). Granulocytes have also been shown to be important in controlling S. ratti infections (40). Evidence that neutrophils were the effector cells against larval S. stercoralis was derived from experiments in which IgM was transferred into IL-5 KO mice. These mice had virtually no eosinophil recruitment into the parasite's microenvironment and yet the larvae were still effectively killed, thus suggesting that neutrophils can function as the effector cells in IgM-dependent immunity (15). Results from the present study regarding the mechanism of IgG-dependent immunity mirrored the results obtained for IgM. Specifically, granulocytes were required, and judging on the basis of the results obtained in studies with IgG transferred into IL-5 KO mice, it appears that neutrophils are the effector cells in IgG-dependent immunity as well. A role for neutrophils in killing N. dubius larvae in vivo in collaboration with IgG has been previously reported (29); in vitro results with A. cantonensis also confirm the function of IgG-dependent and complement-dependent neutrophil cytotoxicity to the infective larvae (34).
FcR
KO mice were immunized with S. stercoralis L3 to investigate
whether the IgM and IgG protection functioned by an antibody-dependent
cellular cytotoxicity (ADCC) mechanism. These animals lack Fc
receptors; consequently, cells cannot bind to IgG, thereby impairing
cell-mediated ADCC (37).
Fc receptor-mediated mechanisms have been shown to be crucial in
controlling primary Strongyloides venezuelensis infections
(28) and resistance to
the microfilariae of Brugia malayi in mice
(11). Immunized
FcR
KO mice that received challenge infections either 1 or 3
weeks after a booster immunization developed protective immunity. These
results can be interpreted to mean either that ADCC dependent on the
presence of IgG is not required for protective immunity or that the
protective IgM found in the serum at both time periods was sufficient
for protective immunity in the absence of a functional IgG
response.
To test the second hypothesis, IgG from mice
immunized with live L3 was transferred into FcR
KO mice; it
was shown that IgG could not transfer immunity to the FcR
KO
mice. FcR
KO mice have also been shown to have a deficit in
neutrophil recruitment into sites of inflammation
(6,
13,
14). In the present
study, neutrophils were recruited in equal numbers in the wild-type and
FcR
KO mice receiving transferred IgG. Therefore, the deficit
in protective immunity after passive transfer of IgG from mice
immunized with live L3 was not caused by an absence of effector cells
but rather suggests a dependency of IgG on ADCC as the mechanism of
larval killing. It is of interest that IgG recovered from mice
immunized with DOC Ag could transfer immunity to the FcR
KO
mice. The difference in the modes of action for the two protective IgGs
may be explained by their different antigenic binding sites, with IgG
from mice immunized with live L3 binding to the cuticle while IgG from
mice immunized with DOC Ag bound only to internal tissues
(17). These experiments
therefore show that IgM from mice immunized with live L3 and IgG from
mice immunized with DOC Ag kill the L3 in an ADCC-independent
mechanism. This result is in contrast to that seen with IgG from mice
immunized with live L3, which appears to function through a classical
ADCC mechanism.
Western blot analyses performed with the protective IgM and IgG from mice immunized with live L3 showed that IgM and IgG each recognized approximately 20 antigens. DOC Ag was used in these analyses, since it was previously demonstrated that lymphocytes from mice immunized with live L3 proliferated and produced IL-5 in response to antigens found in DOC Ag and not to antigens soluble in PBS (17). Of the 20 recognized antigens, only 8 were recognized by both IgM and IgG. Immunoelectron microscopy was performed to determine where the protective IgM and IgG bound to the larvae. It was determined that IgM bound to the surface of the cuticle, the basal cuticle-hypodermis, the coelomic cavity, and the glandular esophagus, whereas IgG bound only to the basal cuticle-hypodermis and the coelomic cavity. Previous studies using fixed intact L3 in indirect fluorescent antibody assays have shown that IgM was the only antibody isotype found to bind to the surface of the larvae (4), thus corroborating the results of the present study.
The antigens jointly recognized by IgM and IgG may be in the basal cuticle-hypodermis and the coelomic cavity, while the antigens uniquely recognized by IgM may be on the surface of the cuticle and in the glandular esophagus. The IgM response which temporally occurs first may be directed at the antigens initially seen by the host, surface antigens, and antigens secreted by the glandular esophagus during the larval migration process. In previous studies it was shown that the protective IgG from mice immunized with DOC Ag recognized seven antigens (17), four of which were also apparently recognized (as determined on the basis of their molecular weights) by the protective IgG from mice immunized with live L3. IgG from mice immunized with DOC Ag was found to bind to the muscles and nerve cord (17). The antigens recognized by IgG from mice immunized with DOC Ag may represent proteins which are normally not seen in the immune response. These antigens may become evident only after the larvae are disrupted and solubilized. Antigens normally concealed from the host were shown to be effective immunogens against the nematodes Haemonchus contortus and Dirofilaria immitis (23, 35, 36). Therefore, it appears that IgG from mice immunized with DOC Ag and IgG from mice immunized with live L3 do not bind to the cuticle of the larvae and differ in the internal organs of the L3 to which they bind. Although they share reactivity with many antigens, the mechanisms by which they kill the larvae are different.
As the immune response to larval
S. stercoralis matures in mice, a protective IgG response
develops which requires complement activation, neutrophils, and
FcR
to function. It appears that killing occurs via an ADCC
mechanism whereby IgG binds to the larvae and the neutrophils then bind
to the Fc portion of the antibody. To kill the larvae, the neutrophils
may then release one of the many toxic molecules which they contain
(26). The hypothesis that
IgG killing of the larvae functions through a classical ADCC mechanism
is difficult to reconcile with the antibody localization studies, since
IgG was found to bind to various internal organs and not to the surface
of the L3. It is possible that the surface antigens to which IgG binds
are not seen in the immunoelectron micrographs because they are
secreted antigens that are loosely bound to the larval surface or
because they represent antigens stripped during the fixation
process.
It is clear from these studies that in the killing of larval S. stercoralis, IgM and IgG from mice immunized with live L3 and IgG from mice immunized with DOC Ag function by using different target antigens and different mechanisms. This finding confirms the observation made with other pathogens that the immune response is pluripotent in its ability to kill pathogens. It is therefore proposed that highly effective vaccines against S. stercoralis infections could be developed that are composed of multiple antigens inducing different types of protective immune responses. The synergy of the different types of protective immune responses would result in a vaccine that could efficiently kill the pathogen regardless of the parasite strain and host genetic background.
We also thank Ofra Leon and Shalom Leon for expert technical assistance. We give special thanks to Yelena Oskov for assistance with the electron microscopy.
|
|
|---|
-knockout mice. Infect. Immun.
68:4968-4971.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»